Please try another search
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Young-Ha Kim | 70 | - | Senior Managing Director, Director of Marketing Division and Director |
Haeng-Sub Jin | 78 | - | Independent Outside Director |
Ho-Young Baek | 62 | - | Director of Operation Support Division and Director |
Gwang-Sub Gil | 76 | - | Independent Outside Director |
Jay Kim | - | - | Chairman & CEO |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review